Therapeutic Solutions International Inc (TSOI)
0.0009
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Therapeutic Solutions International Enterprise Value: 5.482M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 5.482M |
| May 30, 2024 | 5.022M |
| May 29, 2024 | 3.887M |
| May 28, 2024 | 4.310M |
| May 24, 2024 | 4.310M |
| May 23, 2024 | 4.310M |
| May 22, 2024 | 4.310M |
| May 21, 2024 | 5.156M |
| May 20, 2024 | 4.310M |
| May 17, 2024 | 4.310M |
| May 16, 2024 | 4.733M |
| May 15, 2024 | 4.945M |
| May 14, 2024 | 4.310M |
| May 13, 2024 | 3.887M |
| May 10, 2024 | 3.464M |
| May 09, 2024 | 3.676M |
| May 08, 2024 | 3.887M |
| May 07, 2024 | 4.310M |
| May 06, 2024 | 4.733M |
| May 03, 2024 | 3.887M |
| May 02, 2024 | 3.676M |
| May 01, 2024 | 3.887M |
| April 30, 2024 | 3.464M |
| April 29, 2024 | 3.887M |
| April 26, 2024 | 3.887M |
| Date | Value |
|---|---|
| April 25, 2024 | 3.676M |
| April 24, 2024 | 3.887M |
| April 23, 2024 | 3.887M |
| April 22, 2024 | 4.310M |
| April 19, 2024 | 4.310M |
| April 18, 2024 | 4.310M |
| April 17, 2024 | 4.310M |
| April 16, 2024 | 4.945M |
| April 15, 2024 | 5.156M |
| April 12, 2024 | 4.522M |
| April 11, 2024 | 4.733M |
| April 10, 2024 | 4.733M |
| April 09, 2024 | 4.522M |
| April 08, 2024 | 4.733M |
| April 05, 2024 | 5.156M |
| April 04, 2024 | 4.945M |
| April 03, 2024 | 5.156M |
| April 02, 2024 | 4.733M |
| April 01, 2024 | 6.002M |
| March 31, 2024 | 5.579M |
| March 28, 2024 | 4.750M |
| March 27, 2024 | 4.557M |
| March 26, 2024 | 4.364M |
| March 25, 2024 | 4.557M |
| March 22, 2024 | 3.978M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.650M
Minimum
Nov 12 2019
335.79M
Maximum
Feb 11 2021
38.57M
Average
14.21M
Median
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 4.387M |
| Palatin Technologies Inc | 19.03M |
| iBio Inc | 28.91M |
| Theriva Biologics Inc | -10.98M |
| Oragenics Inc | 8.699M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5851M |
| Revenue (Quarterly) | 0.0218M |
| Total Expenses (Quarterly) | 0.6951M |
| EPS Diluted (Quarterly) | -0.0001 |
| Gross Profit Margin (Quarterly) | 65.66% |
| Profit Margin (Quarterly) | -2.68K% |
| Earnings Yield | -69.11% |
| Normalized Earnings Yield | -74.00 |